Viraj A. Master

14.5k total citations · 3 hit papers
471 papers, 8.5k citations indexed

About

Viraj A. Master is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Viraj A. Master has authored 471 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 246 papers in Pulmonary and Respiratory Medicine, 181 papers in Surgery and 153 papers in Oncology. Recurrent topics in Viraj A. Master's work include Renal cell carcinoma treatment (159 papers), Bladder and Urothelial Cancer Treatments (97 papers) and Prostate Cancer Diagnosis and Treatment (60 papers). Viraj A. Master is often cited by papers focused on Renal cell carcinoma treatment (159 papers), Bladder and Urothelial Cancer Treatments (97 papers) and Prostate Cancer Diagnosis and Treatment (60 papers). Viraj A. Master collaborates with scholars based in United States, United Kingdom and Japan. Viraj A. Master's co-authors include Kenneth Ogan, Ashesh B. Jani, Mehmet Asım Bilen, Timothy V. Johnson, Peter T. Nieh, David M. Schuster, Shishir K. Maithel, Peter R. Carroll, Jack W. McAninch and Adeboye O. Osunkoya and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Viraj A. Master

426 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology

2017 396 citations Mehmet Asım Bilen, Ashesh B. Jani et al. profile →
CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor

2022 168 citations Maria A. Cardenas, Ewelina Sobierajska et al. profile →
Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline

2022 139 citations Viraj A. Master et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Viraj A. Master United States	47	3.7k	2.6k	2.1k	1.3k	961	471	8.5k
Angel M. Cronin United States	55	4.1k 1.1×	3.0k 1.2×	2.4k 1.1×	982 0.7×	614 0.6×	206	11.7k
Armen Aprikian Canada	48	4.2k 1.1×	3.0k 1.2×	2.0k 0.9×	2.2k 1.7×	456 0.5×	279	8.7k
Jan Adolfsson Sweden	52	5.1k 1.4×	1.9k 0.7×	2.4k 1.1×	1.2k 0.9×	551 0.6×	246	9.5k
Daniel M. Green United States	69	4.6k 1.3×	1.3k 0.5×	2.6k 1.2×	6.1k 4.6×	684 0.7×	282	16.9k
Yoichi Arai Japan	51	4.3k 1.2×	3.3k 1.3×	1.1k 0.5×	2.2k 1.7×	569 0.6×	525	10.3k
Michael S. Cookson United States	68	7.1k 1.9×	7.5k 3.0×	2.2k 1.0×	1.6k 1.2×	1.0k 1.1×	310	14.7k
Mieke Van Hemelrijck United Kingdom	47	2.4k 0.7×	1.5k 0.6×	2.3k 1.1×	1.3k 1.0×	420 0.4×	364	7.8k
Paul L. Nguyen United States	62	9.6k 2.6×	2.8k 1.1×	4.8k 2.3×	1.7k 1.3×	1.9k 2.0×	558	16.6k
Adam S. Kibel United States	60	8.7k 2.4×	4.6k 1.8×	3.4k 1.6×	3.3k 2.5×	1.1k 1.2×	605	15.9k
Michele Gallucci Italy	49	5.1k 1.4×	3.0k 1.2×	885 0.4×	1.5k 1.1×	785 0.8×	364	10.1k

Countries citing papers authored by Viraj A. Master

Since Specialization

Citations

This map shows the geographic impact of Viraj A. Master's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viraj A. Master with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viraj A. Master more than expected).

Fields of papers citing papers by Viraj A. Master

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viraj A. Master. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viraj A. Master. The network helps show where Viraj A. Master may publish in the future.

Co-authorship network of co-authors of Viraj A. Master

This figure shows the co-authorship network connecting the top 25 collaborators of Viraj A. Master. A scholar is included among the top collaborators of Viraj A. Master based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viraj A. Master. Viraj A. Master is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Wei, Hajime Tanaka, Masaki Kobayashi, et al.. (2025). Racial disparity in preoperative C‐reactive protein level for predicting prognosis of patients with non‐metastatic clear cell renal cell carcinoma: INMARC study. International Journal of Urology. 32(4). 414–422. 2 indexed citations

Hakimi, Kevin, Margaret Meagher, Franklin Liu, et al.. (2024). SHIFTING THE PARADIGM: THE INTRIGUING ROLE OF C-REACTIVE PROTEIN IN RENAL CELL CARCINOMA STAGING WITHIN THE AJCC SYSTEM -ANALYSIS OF THE INMARC REGISTRY. Urologic Oncology Seminars and Original Investigations. 42. S41–S41. 1 indexed citations

Master, Viraj A., et al.. (2024). Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches. The Oncologist. 29(9). 738–746. 7 indexed citations

Master, Viraj A., et al.. (2024). Multidisciplinary management of chylous ascites following resection of a retroperitoneal, functional Paraganglioma. Urology Case Reports. 57. 102888–102888.

Fang, Junnan, Dattatraya Patil, Kenneth Ogan, et al.. (2024). A missense SNP in the tumor suppressor SETD2 reduces H3K36me3 and mitotic spindle integrity in Drosophila. Genetics. 226(4). 1 indexed citations

Patel, Jimmy S., Caroline S. Jansen, Jennifer W. Carlisle, et al.. (2024). Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis. Journal for ImmunoTherapy of Cancer. 12(3). e008011–e008011. 14 indexed citations

Cardenas, Maria A., Nataliya Prokhnevska, Caroline S. Jansen, et al.. (2023). Stem-like CD4 T differentiation controls CD8 T cell immunity or tolerance in cancer. The Journal of Immunology. 210(Supplement_1). 86.04–86.04.

Patil, Dattatraya, R. Donald Harvey, Janetta Bryksin, et al.. (2023). Race‐free renal function estimation equations and potential impact on Black patients: Implications for cancer clinical trial enrollment. Cancer. 129(6). 920–924. 4 indexed citations

Nazha, Bassel, Sharon Wu, Jacqueline T. Brown, et al.. (2023). Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers. Cancer. 129(24). 3884–3893. 21 indexed citations

10.

Shah, Yash, et al.. (2023). Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma. SHILAP Revista de lepidopterología. 21(3). 183–199. 1 indexed citations

11.

Lawal, Ismaheel O., Charles Marcus, David M. Schuster, et al.. (2023). Impact of 18F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy. Clinical Nuclear Medicine. 48(4). e153–e159. 6 indexed citations

12.

Saito, Kazutaka, Yosuke Yasuda, Hajime Tanaka, et al.. (2022). Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. Clinical Genitourinary Cancer. 20(4). e276–e282. 2 indexed citations

13.

Bandini, Marco, Mohamed E. Ahmed, Giuseppe Basile, et al.. (2022). Author Correction: A global approach to improving penile cancer care. Nature Reviews Urology. 19(4). 253–253. 2 indexed citations

14.

Patil, Dattatraya, Vikram M. Narayan, Viraj A. Master, et al.. (2021). Longitudinal impact of bladder cancer diagnosis on common psychiatric disorders. Cancer Medicine. 10(23). 8412–8420. 9 indexed citations

15.

Bandini, Marco, Mohamed E. Ahmed, Giuseppe Basile, et al.. (2021). A global approach to improving penile cancer care. Nature Reviews Urology. 19(4). 231–239. 34 indexed citations

16.

Chen, Ronald C., Henry N. Young, Anant Mandawat, et al.. (2021). Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancer. Prostate Cancer and Prostatic Diseases. 24(4). 1093–1102. 2 indexed citations

17.

Figlin, Robert A., Nizar M. Tannir, Robert G. Uzzo, et al.. (2020). Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma. Clinical Cancer Research. 26(10). 2327–2336. 53 indexed citations

18.

Necchi, Andrea, et al.. (2020). Utility of Minimally Invasive Technology for Inguinal Lymph Node Dissection in Penile Cancer. Journal of Clinical Medicine. 9(8). 2501–2501. 8 indexed citations

19.

Shabto, Julie M., Dylan J. Martini, Yuan Liu, et al.. (2020). Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. Cancer Medicine. 9(8). 2752–2760. 8 indexed citations

20.

Akbari, Hamed, Luma V. Halig, David M. Schuster, et al.. (2012). Hyperspectral imaging and quantitative analysis for prostate cancer detection. Journal of Biomedical Optics. 17(7). 760051–760051. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact